1- (1-Benzothiophen-4-yl) piperazine Hydrochloride CAS 913614-18-3 Tsarkake>98.0% (HPLC) Brexpiprazole Intermediate Factory

Takaitaccen Bayani:

1- (1-Benzothiophen-4-yl) Piperazine Hydrochloride

Saukewa: 913614-1

Tsafta:> 99.0% (HPLC)

Bayyanar: Fari zuwa Kashe-Farin Foda

Matsakaicin Brexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Abubuwan Sinadarai:

Sunan Sinadari 1- (1-Benzothiophen-4-yl) Piperazine Hydrochloride
Makamantu Brexpiprazole Matsakaici 2;1-Benzo[b]thien-4-yl-Piperazine Hydrochloride;1-Benzo[b]thien-4-ylpiperazine Monohydrochloride
Lambar CAS 913614-18-3
Lambar CAT Saukewa: RF-PI1034
Matsayin Hannun jari A cikin Hannun jari, Ƙarfin Ƙirƙirar 100MT/Shekara
Tsarin kwayoyin halitta Saukewa: C12H15ClN2S
Nauyin Kwayoyin Halitta 254.7789
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Fari zuwa Kashe-Farin Foda
Ganewa Lokacin riƙe samfurin yayi daidai da na ƙa'idar tunani
Tsarkake / Hanyar Bincike > 99.0% (HPLC)
Asara akan bushewa <0.50%
Ruwa (KF) <0.50%
Ragowa akan Ignition <0.20%
Abubuwa masu alaƙa (HPLC)
Duk wani Rashin Tsabtace Mutum <0.50%
Jimlar ƙazanta <1.00%
Infrared Spectrum Yayi daidai da Tsarin
Abubuwan da aka bayar na Proton NMR Spectrum Yayi daidai da Tsarin
Matsayin Gwaji Matsayin Kasuwanci
Amfani Matsakaicin Brexpiprazole (CAS: 913611-97-9)

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi

Amfani:

1

FAQ:

Aikace-aikace:

1- (1-Benzothiophen-4-yl) piperazine Hydrochloride (CAS: 913614-18-3) matsakaici ne na Brexpiprazole (CAS: 913611-97-9).Brexpiprazole wani nau'i ne na antipsychotic mai lalacewa.Yana da mai karɓa na D2 mai karɓa na agonist.A matsayin novel Serotonin-dopamine aiki modulator, ana iya amfani da shi don maganin schizophrenia, da kuma maganin haɗin gwiwa don baƙin ciki.Hakanan yana iya ba da inganci da juriya akan kafaffen jiyya na rashin jin daɗi (MDD).Magungunan yana nuna bayanin martaba na musamman na pharmacological, yana aiki azaman agonist na serotonin 5-HT1A da masu karɓa na dopamine D2 kuma a matsayin cikakken antagonist na 5-HT2A da noradrenaline α1B / 2C masu karɓa, tare da alaƙar haɗin kai na subnanomolar iri ɗaya.Magungunan, wanda Otsuka da Lundbeck suka kirkira, an amince da shi a cikin 2015 ta FDA don maganin schizophrenia da kuma a matsayin ƙarin magani don damuwa.

Ku rubuta sakonku anan ku aiko mana